Hyundai Motor India enters coverage with a BUY recommendation from ICICI Securities, backed by a target price of Rs 2,150, implying an upside potential of roughly 21% from the current market price of Rs 1,778. The investment thesis hinges on an aggressive upcoming product cycle, strong parentage, and improving premium positioning. However, recent underperformance in market share, rising competition, and overdependence on a few key models remain structural concerns. The success of planned launches over FY26–30 will be the defining catalyst for future growth trajectory.

Investment Call and Valuation Framework

BUY rating anchored on growth visibility and valuation comfort

ICICI Securities initiates coverage on Hyundai Motor India with a BUY call, valuing the company at 25x FY28E EPS. This yields a target price of Rs 2,150. The brokerage expects revenue, EBITDA, and PAT to grow at a CAGR of approximately 9%, 13%, and 12%, respectively, over FY26–28E.

The valuation reflects confidence in Hyundai’s ability to regain market share through a renewed product strategy while maintaining robust return ratios.

Market Share Erosion Raises Strategic Concerns

Loss of domestic PV and UV market share highlights execution gaps

Hyundai Motor India has witnessed a steady erosion in domestic passenger vehicle (PV) market share, declining by nearly 490 basis points over FY20–9MFY26 to about 12.6%. This underperformance becomes more evident when compared to industry growth trends.

Despite favorable macro tailwinds such as GST cuts and strong industry recovery (18% growth during Oct’25–Feb’26), Hyundai’s retail growth lagged significantly at just 8%.

The company’s utility vehicle (UV) segment—once a stronghold—also saw a decline in market share by over 500 basis points during the same period, indicating intensifying competitive pressures.

Overdependence on Creta and Venue Remains a Structural Risk

High reliance on a limited portfolio constrains scalability

A critical vulnerability in Hyundai’s strategy is its heavy dependence on flagship models such as Creta and Venue. These two models now contribute approximately 55% of total volumes, up from 36% in FY20.

While Creta’s full model change (FMC) successfully boosted volumes, most other product introductions over the past five years—such as Exter and Aura—have delivered only moderate success. This imbalance has led to brand concentration risk and reduced resilience against competition.

Product Pipeline: The Key Catalyst for Revival

26 product interventions planned to address portfolio gaps

Hyundai has outlined an ambitious roadmap comprising 26 product interventions between FY26 and FY30, including:

7 new nameplates
6 full model changes (FMCs)
Multiple facelifts and derivatives

The company aims to fill “whitespace” opportunities in segments such as MPVs, crossover SUVs, and compact EVs. Expected launches could include models like Stargazer (MPV), Bayon (crossover SUV), and Inster EV.

This strategic expansion is designed to reduce overdependence on existing models and improve market share across segments.

Premiumisation Strategy Continues to Deliver

Shift toward higher-value segments strengthens brand positioning

One of Hyundai’s key strengths has been its early and effective pivot toward premiumisation. The share of vehicles priced in the Rs 1–2 million bracket has risen significantly, becoming the dominant contributor to overall volumes.

Simultaneously, the contribution of entry-level vehicles (below Rs 1 million) has declined, reflecting a conscious move toward higher-margin offerings.

This transition has enhanced brand perception and profitability, positioning Hyundai as a premium mass-market player.

Export Growth: Near-Term Tailwind, Long-Term Constraint

Capacity expansion supports exports, but global overlap limits upside

Hyundai’s export volumes have grown modestly over the past decade, constrained by capacity limitations. The upcoming Talegaon plant is expected to add 250,000 units annually by 2028, providing a near-term boost.

However, long-term export growth may remain capped due to Hyundai Motor Company’s extensive global manufacturing footprint, which reduces reliance on India as an export hub.

Financial Outlook and Key Metrics

Steady growth expected with improving margins

Hyundai’s financial trajectory remains stable, with gradual improvement expected over the medium term:

Return ratios, although moderating, remain healthy with ROCE expected near 25% levels.

Competitive Landscape Intensifies

Rising competition from incumbents and new entrants pressures growth

Hyundai faces stiff competition from established players such as Maruti Suzuki and Tata Motors, as well as aggressive entrants like Kia. These competitors have launched multiple successful models across segments, eroding Hyundai’s market share.

Additionally, aggressive pricing strategies and discounting by rivals have impacted Hyundai’s sales momentum, particularly in the entry and mid-segments.

Key Risks to the Investment Thesis

Execution and macro risks could derail growth expectations

Investors should closely monitor the following risks:

Weak response to upcoming product launches
Slower industry growth due to geopolitical uncertainties
Rising commodity prices impacting margins
Failure to meet fuel efficiency (CAFE) norms

The success of the upcoming product cycle remains the most critical variable.

Final Take: A Strategic Rebuild Story with Execution Dependency

Growth hinges on successful product launches and portfolio diversification

Hyundai Motor India stands at a strategic inflection point. While its strong parentage, premium positioning, and robust financials provide a solid foundation, recent market share erosion underscores execution challenges.

The planned product offensive over FY26–30 offers a credible pathway to regain lost ground. However, the turnaround is contingent on successful execution and favorable market reception.

With a target price of Rs 2,150, the stock offers meaningful upside, but investors must remain vigilant about near-term risks and competitive dynamics.